Patient Rating:

4.6 out of 5

45 Patient Ratings
22 Patient Comments

Stavros G. Drakos, M.D., Ph.D.

Patient Rating:

4.6 out of 5

45 Patient Ratings
22 Patient Comments

Clinical Details

Phone Number Clinical Office Address
(801) 585-3693 University Hospital
Heart Transplant Clinic
50 N Medical Dr
Salt Lake City, UT 84132
Map
(801) 585-5122 University Hospital
Heart Failure Clinic
50 N Medical Dr
Salt Lake City, UT 84132
Map

Bio

Stavros G. Drakos, MD/PhD is an Associate Professor of Cardiology with Tenure and the Medical Director of the Cardiac Mechanical Support Program.

Training

1. M.D. (Summa Cum Laude) from the University of Athens School of Medicine (ranked as one of the leading medical school worldwide: http://school.med.uoa.gr/en/), and PhD from the same university with a PhD thesis entitled: “Pulsatile vs. non-pulsatile cardiac mechanical support in a porcine model of heart failure” (Award "Top 3 PhD Theses", Univ. of Athens).

2. Internal Medicine residency and General Cardiology Fellowship at the Univ. of Athens (his mentor in Athens, John N. Nanas, MD/PhD, worked during the 80's for several years here at the Univ. of Utah: initially with the Total Artificial Heart development team and later he patented here a novel para-aortic counterpulsation device).

3. Heart Failure (HF)/ Transplant/ Cardiac Mechanical Support Fellowships at the Univ. of Utah/ UTAH Cardiac Transplant Program (Mentors: Dale G. Renlund, MD, and E.M. Gilbert, MD).

Post-training Faculty Appointments

1. In 2006, after finishing his cardiology and HF fellowships, Dr. Drakos joined the faculty at the Univ. of Athens Cardiology/Clinical Therapeutics Department. Clinically, he leveraged his advanced HF training in the US and played a pivotal role in starting and establishing the first VAD program in Greece. Academically, he focused his research efforts on advancing the "Harefield-Athens Cardiac Recovery Program" in collaboration with Sir Magdi Yacoub, Harefield/ Imperial College London.

2. Four years later he returned at the University of Utah and since 2009 he has been faculty at the Division of Cardiovascular Medicine.

Dr. Drakos is licensed to practice medicine both in the US and the European Union and is a member of the American Heart Association (AHA), European Society of Cardiology (ESC), Heart Failure Society of America (HFSA), International Society for Heart and Lung Transplantation (ISHLT), Heart Failure Association of European Society Cardiology (HFA/ESC) and others.

He serves in several national and international Medical Committees and Advisory Boards in the fields of Heart Failure, Mechanical Circulatory Support and Heart Transplantation. He also serves in the Editorial Board of medical journals and Research Grant Review Committees both in the US and Europe (British Heart Foundation and others). Dr. Drakos has published more than 100 peer-reviewed scientific manuscripts and book chapters. He and his mentees have received over the years several national and international competitive scientific Awards.

What kind of patients Dr. Drakos sees?

His clinical specialties are General Cardiology, Heart Failure and Cardiomyopathies (including valvular heart disease), Heart Transplantation, Cardiac Mechanical Support (VAD) and Cardiovascular Intensive Care Unit (CV-ICU). For appointments please call 801-585-5122, Cardiovascular Center, University of Utah Hospitals and Clinics.

Board Certification and Academic Information

Academic Departments Internal Medicine - Associate Professor
Academic Divisions Cardiovascular Medicine
Board Certification Board Certified in Cardiology (European Union and European Commission Board Certification)

Patient Ratings

The Patient Rating score is an average of all responses to care provider related questions on our nationally-recognized Press Ganey Patient Satisfaction Survey.

Responses are measured on a scale of 1 to 5 with 5 being the best score.

Likelihood of recommending care provider
4.7
My confidence in care provider
4.6
Time care provider spent with me
4.5
Care provider spoke using clear language
4.7
Care provider's effort to include me in decisions
4.6
Care provider's concern for questions & worries
4.6
Care provider's explanation of condition/problem
4.6
Wait time at clinic
4.2
Care provider's friendliness and courtesy
4.6

Patient Comments

Patient comments are gathered from our Press Ganey Patient Satisfaction Survey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.

June 15, 2015

the care provider was so good help me with everthing

May 18, 2015

appreciate the care and kindness shown.

May 08, 2015

I would recommend U of U to anybody!!

April 19, 2015

Excellent experience in discussing alternatives in decisions that we made.

April 07, 2015

We needed medical help & we got it...THANK YOU VERY MUCH

April 07, 2015

I have nothing but the utmost respect for Dr. Draccos and complete confidence in him as a cardiologist. Extremely professional and a pleasure to see!

December 27, 2014

Excellent care

November 19, 2014

Doctor was a new one to me. Was not too sure about him.

November 14, 2014

My appointment was very through I had med changes with a follow-up call at home with orders phoned in to the lab for follow-up test My quality of life has improved 180%

July 07, 2014

Since we were in for a test, no results were available for the doctor or PA to share with us. They had seen us before, and were aware of the conditions, and of our concerns.

June 23, 2014

My previous appointment I was told that my heart may be getting worse and there was talk about ventricular assist or other items. It appears that my heart is the same as it was over the last few years based on the Echo. However, the problem of low BP and low Oxygen levels when active have not been addressed

February 18, 2014

Dr. Drakos was excellent, I was confident in his care and his attention to my concerns and issues. I agree with the comment that I read from another patient..... it would be beneficial to me to be able to listen to the discussion between the nurse and doctor. It would improve my understanding of my case and increase my peace of mind.

November 13, 2013

I really like Dr. Drakos. He is the only Dr. there who has been willing to think outside the box somewhat. He has been a big help when is comes to the breathing problems I was having. However, no one there has been willing or maybe able to address and figure out why my blood pressure drops so low so often since I had my defibrillator put in. No one seems curious enough to try to find out why. I bring it up at every visit but they don't know what to do about it so they simply tell me not to worry about it. This is frustrating for me! They don't have to live with the problem, I DO! and I'm tired of it. It is frustrating and debilitating in so many ways. If y'all can't figure it out please send me to someone who can, I would so appreciate it!

November 08, 2013

very good

October 22, 2013

all have treated me great

July 09, 2013

Dr. Drakos is really the only doctor in your office who has really taken an interest in the problems and symptoms I have. He's the only doctor who has taken the time to think outside the box and really try to find out what is going on with me. I have felt utterly dismissed by the other doctors in the Cardiology department. Because they couldn't find anything glaringly wrong with my heart they have basically ignored me. Dr. Drakos studied my chart and realized, because of my history, it could be something other than my heart causing my symptoms. Because of his expertise and inquisitiveness I think we might make some progress. At least he makes me feel that I am worth his time and effort and you can't possibly know how much that means to me. The other doctors in your office could take a few lessons from him. THINK OUTSIDE THE BOX!!!!!!

July 08, 2013

We have had an incredible experience with the facility and all staff!

July 01, 2013

from the reception to the doctor,all of them are exeptional!

June 24, 2013

The entire team that saw me was very interested in my symptoms and my case. This is something I have never experienced before. They did not tell me that, "it was all in my head" as many other physicians I have seen regarding these episodes have. They asked very thorough questions regarding my episodes, and wrote everything down. Over the past 6 years, I have never found a team of physicians that have helped me as much as they have.

April 29, 2013

I was treated like. person. with concern and care. I am asked if I understand my condition and explained what I don't. I am explained what is happening to me. I am reassured that I am in good hands. and I feel at ease because I am being talked to and looked at.

April 24, 2013

excellent service

October 29, 2012

This was the first time I met with the doctor, He did apologize for running so late, which was nice.

Academic Profile

Board Certification and Academic Information

Academic Departments Internal Medicine - Associate Professor
Academic Divisions Cardiovascular Medicine
Board Certification Board Certified in Cardiology (European Union and European Commission Board Certification)

Academic Office Locations

Academic Office Phone Number Academic Office Address
(801) 585-0700 George and Dolores Eccles Institute of Human Genetics
Molecular Medicine Program
15 N 2030 E
Salt Lake City, UT 84112
(801) 585-2340 School of Medicine
Division of Cardiovascular Medicine
30 N 1900 E
Salt Lake City, UT 84132

Academic Bio

Stavros G. Drakos, MD/PhD is an Associate Professor of Medicine with Tenure, Medical Director of the University of Utah Cardiac Mechanical Support Program and an Investigator at the Molecular Medicine Program, Eccles Institute of Human Genetics.

Dr. Drakos serves in the Editorial Board of peer-reviewed scientific journals and Grant Review Committees in the US and Europe (British Heart Foundation and others). He has published more than 100 manuscripts and book chapters and succeeded in acquiring extramural peer-reviewed research funding both in the US and Europe. Dr. Drakos and his mentees have received over the years several national and international competitive scientific Awards. He also serves in several national and international scientific Committees and Advisory Boards in the fields of Heart Failure, Mechanical Circulatory Support and Heart Transplantation.

Research Interests

Dr Drakos's primary research interests are focused on Mechanical Unloading and Cardiac Recovery in Chronic Heart Failure. Similarly, he is also interested in unloading and recovery in Acute Heart Failure and Cardiogenic Shock. He has been advancing a cardiac recovery clinical and translational research program through a tight collaboration between the UTAH Advanced HF/VAD/Transplant program, the Cath Lab clinical services and the Molecular Medicine Program/ Eccles Institute of Human Genetics where Dr. Drakos's lab is located.

Information about the Annual International Utah Cardiac Recovery Symposium (U-CARS): http://medicine.utah.edu/cardiacrecoverysymposium/

Direct Contact Info for Collaborations

Cardiac Mechanical Support Program, Division of Cardiovascular Medicine, University of Utah, 30 North 1900 East, Room 4A100 SOM, Salt Lake City, 84132, UT, Email: stavros.drakos@hsc.utah.edu, Office: 801-5852340, Clinic: 801-5855122, Fax: 801-5852319

Research Grants

1). Doris Duke Foundation Research Grant

2). VA Merit Award

3). Deseret Foundation IRMF Grant

Completed Research Grants

1). European Union (EU) Research Executive Agency (Brussels, Belgium) - FP7 Marie Curie Grant

Title: Unload failing heart

2). Clinical and Translational Science Award Institutions - CTSA/ NIH

Title: Reverse remodeling during mechanical unloading of the left ventricle

3). A. G. Leventis Foundation, Zurich, Switzerland - Young Investigator Grant- Experimental Cardiology

Title: Pulsatile versus non-pulsatile unloading in experimental heart failure.

4). General Secretariat for Research and Technology, European Union, EU - PENED/ 1999

Title: Hemodynamic effects during cardiac mechanical support in an in vitro-mock circulation model.

5). Bodossakis Foundation, Athens, Greece - Young Investigator Grant- Experimental Cardiology

Title: Pulsatile versus non-pulsatile mechanical circulatory support in a porcine model of cardiogenic shock.

Ongoing Clinical Trials

1) RESTAGE, Remisision from Stage D Heart Failure, VAD Bridge-To-Recovery trial (Thoratec Corporation)

2) IRONOUT-HF, Oral iron in HF patients with or without anemia (NIH/ NHLBI - HF Clinical Research Network)

3) DREAM-HF, Allogeneic Mesenchymal Precursor Cells in Patients with Chronic Heart Failure (Teva Pharmaceuticals)

4) CTOT, Clinical Trials in Transplantation - Prevention of coronary allograft vasculopathy with Rituximab (NIH)

5) ENDURANCE, Randomized trial of HeartMate II vs Heartware for destination therapy (HeartWare, Inc)

6) CTS NIH NETWORK, Safety and efficacy of intramyocardial injection of mesenchymal precursor cells in LVAD recipients (NIH)

7) ROADMAP, Risk assessment and comparative effectiveness of left ventricular assist device and medical management

in ambulatory heart failure patients (Thoratec Corporation)

Education

Education History

Type School Degree
Fellowship University of Athens
General Cardiology Fellowship
Fellow
Fellowship University of Utah & U.T.A.H. Cardiac Transplant Program
Heart Failure/ Transplant/ Mechanical Support Fellowship
Fellow
Doctoral Training University of Athens
Pulsatile vs. Non Pulsatile Mechanical Support in a Porcine Model of Heart Failure, Summa Cum Laude
Ph.D.
Residency University of Athens
Internal Medicine
Resident
Professional Medical University of Athens
Medicine, Summa Cum Laude
M.D.

Publications

Selected Provider Publications

Journal Article

  1. Abdullah OM, Drakos SG, Diakos NA, Wever-Pinzon O, Kfoury AG, Stehlik J, Selzman CH, Reid BB, Brunisholz K, Verma DR, Myrick C, Sachse FB, Li DY, Hsu EW (2014). Characterization of diffuse fibrosis in the failing human heart via diffusion tensor imaging and quantitative histological validation.LID - 10.1002/nbm.3200 [doi]. (Epub ahead of print) NMR Biomed.
  2. Madden JL, Drakos SG, Stehlik J, McKellar SH, Rondina MT, Weyrich AS, Selzman CH (2014). Baseline Red Blood Cell Osmotic Fragility Does Not Predict the Degree of Post-LVAD Hemolysis. ASAIO J, 60(5), 524-8.
  3. Park SY, Gifford JR, Andtbacka RH, Trinity JD, Hyngstrom JR, Garten RS, Diakos NA, Ives SJ, Dela F, Larsen S, Drakos S, Richardson RS (2014). Cardiac, skeletal, and smooth muscle mitochondrial respiration: are all mitochondria created equal? Am J Physiol Heart Circ Physiol, 307(3), H346-52.
  4. Wever-Pinzon O, Romero J, Kelesidis I, Wever-Pinzon J, Manrique C, Budge D, Drakos SG, Pina IL, Kfoury AG, Garcia MJ, Stehlik J (2014). Coronary computed tomography angiography for the detection of cardiac allograft vasculopathy: a meta-analysis of prospective trials. J Am Coll Cardiol, 63(19), 1992-2004.
  5. Diakos NA, Selzman CH, Sachse FB, Stehlik J, Kfoury AG, Wever-Pinzon O, Catino A, Alharethi R, Reid BB, Miller DV, Salama ME, Zaitsev AV, Shibayama J, Li H, Fang JC, Li DY, Drakos SG (In press). Myocardial atrophy and metabolic changes during mechanical unloading of the failing human heart: implications for ventricular assist devices-induced cardiac recovery. J Am Coll Cardiol.
  6. Drakos SG (2014). The Odyssey of Chronic Cardiac Mechanical Support. J Am Coll Cardiol, Feb 27.
  7. Omar Wever-Pinzon, Jorge Romero, Iosif Kelesidis, James Wever-Pinzon, Carlos Manrique, Deborah Budge, Drakos SG, Ileana Pina, Abdallah G Kfoury, Mario J Garcia, Josef Stehlik (3/2014). Coronary Computed Tomography Angiography for the Detection of Cardiac Allograft Vasculopathy: A Meta-Analysis of Prospective Trials ONLINE FIRST. J Am Coll Cardiol.
  8. Wozniak CJ, Stehlik J, Baird BC, McKellar SH, Song HK, Drakos SG, Selzman CH (2014). Ventricular Assist Devices or Inotropic Agents in Status 1A Patients? Survival Analysis of the United Network of Organ Sharing Database.LID - S0003-4975(13)02402-8 [pii]LID - 10.1016/j.athoracsur.2013.10.077 [doi]. (Epub ahead of print) Ann Thorac Surg.
  9. Frech T, De Domenico I, Murtaugh MA, Revelo MP, Li DY, Sawitzke AD, Drakos SG (2014). Autophagy is a key feature in the pathogenesis of scytemic sclerosis. Rheumatol Int, 34(3), 435-439.
  10. Drakos SG, Wever-Pinzon O, Selzman CH, Gilbert EM, Alharethi R, Reid BB, Saidi A, Diakos NA, Stoker S, Davis ES, Movsesian M, Li DY, Stehlik J, Kfoury AG (2013). Magnitude and time course of changes induced by continuous-flow left ventricular assist device unloading in chronic heart failure: insights into cardiac recovery. J Am Coll Cardiol, 61(19), 1985-94.
  11. Wever-Pinzon O, Selzman CH, Drakos SG, Saidi A, Stoddard GJ, Gilbert EM, Labedi M, Reid BB, Davis ES, Kfoury AG, Li DY, Stehlik J, Bader F (2013). Pulsatility and the Risk of Nonsurgical Bleeding in Patients Supported With the Continuous-Flow Left Ventricular Assist Device HeartMate II. Circ Heart Fail, 6(3), 517-26.
  12. Wever-Pinzon O, Kfoury AG, Selzman CH, Li DY, Drakos SG (2013). Left ventricular assist devices in chronic heart failure: more questions than answers? J Am Coll Cardiol, 62(23), 2257-8.
  13. Healy AH, Baird BC, Drakos SG, Stehlik J, Selzman CH (2013). Impact of ventricular assist device complications on posttransplant survival: an analysis of the United network of organ sharing database. Ann Thorac Surg, 95(3), 870-5.
  14. Wever-Pinzon O, Drakos SG, Kfoury AG, Nativi JN, Gilbert EM, Everitt M, Alharethi R, Brunisholz K, Bader FM, Li DY, Selzman CH, Stehlik J (2013). Morbidity and mortality in heart transplant candidates supported with mechanical circulatory support: is reappraisal of the current United network for organ sharing thoracic organ allocation policy justified? Circulation, 127(4), 452-62.
  15. Drakos SG, Kfoury AG, Stehlik J, Selzman CH, Reid BB, Terrovitis JV, Nanas JN, Li DY (2012). Bridge to recovery: understanding the disconnect between clinical and biological outcomes. Circulation, 126(2), 230-41.
  16. Frech TM, Revelo MP, Drakos SG, Murtaugh MA, Markewitz BA, Sawitzke AD, Li DY (2012). Vascular Leak Is a Central Feature in the Pathogenesis of Systemic Sclerosis. (Epub ahead of print) J Rheumatol.
  17. Wozniak CJ, Baird BC, Stehlik J, Drakos SG, Bull DA, Patel AN, Selzman CH (2012). Improved survival in heart transplant patients living at high altitude. J Thorac Cardiovasc Surg, 143(3), 735-741.e1.
  18. Revelo MP, Miller DV, Stehlik J, Brunisholz K, Drakos S, Gilbert EM, Everitt M, Budge D, Alharethi R, Snow G, Hammond EH, Kfoury AG (2012). Longitudinal evaluation of microvessel density in survivors vs. nonsurvivors of cardiac pathologic antibody-mediated rejection. (Epub ahead of print) Cardiovasc Pathol.
  19. Kfoury AG, Snow GL, Budge D, Alharethi RA, Stehlik J, Everitt MD, Miller DV, Drakos SG, Reid BB, Revelo MP, Gilbert EM, Selzman CH, Bader FM, Connelly JJ, Hammond ME (2012). A longitudinal study of the course of asymptomatic antibody-mediated rejection in heart transplantation. J Heart Lung Transplant, 31(1), 46-51.
  20. Wever Pinzon O, Stoddard G, Drakos SG, Gilbert EM, Nativi JN, Budge D, Bader F, Alharethi R, Reid B, Selzman CH, Everitt MD, Kfoury AG, Stehlik J (2011). Impact of donor left ventricular hypertrophy on survival after heart transplant. Am J Transplant, 11(12), 2755-61.
  21. Dimopoulos S, Diakos N, Tseliou E, Tasoulis A, Mpouchla A, Manetos C, Katsaros L, Drakos S, Terrovitis J, Nanas S (2011). Chronotropic incompetence and abnormal heart rate recovery early after left ventricular assist device implantation. Pacing Clin Electrophysiol, 34(12), 1607-14.
  22. Healy AH, Mason NO, Hammond ME, Reid BB, Clayson SE, Drakos SG, Kfoury AG, Patel AN, Bull DA, Budge D, Alharethi RA, Bader FM, Gilbert EM, Stehlik J, Selzman CH (2011). Allograft rejection in patients supported with continuous-flow left ventricular assist devices. Ann Thorac Surg, 92(5), 1601-7; discussion 1607.
  23. Pierrakos CN, Bonios MJ, Drakos SG, Charitos EI, Tsolakis EJ, Ntalianis A, Nanas SN, Charitos CE, Nanas JN, Terrovitis JV (2011). Mechanical assistance by intra-aortic balloon pump counterpulsation during reperfusion increases coronary blood flow and mitigates the no-reflow phenomenon: an experimental study. Artif Organs, 35(9), 867-74.
  24. Nativi JN, Drakos SG, Kucheryavaya AY, Edwards LB, Selzman CH, Taylor DO, Hertz MI, Kfoury AG, Stehlik J (2011). Changing outcomes in patients bridged to heart transplantation with continuous- versus pulsatile-flow ventricular assist devices: an analysis of the registry of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant, 30(8), 854-61.
  25. Chan AC, Drakos SG, Ruiz OE, Smith AC, Gibson CC, Ling J, Passi SF, Stratman AN, Sacharidou A, Revelo MP, Grossmann AH, Diakos NA, Davis GE, Metzstein MM, Whitehead KJ, Li DY (2011). Mutations in 2 distinct genetic pathways result in cerebral cavernous malformations in mice. J Clin Invest, 121(5), 1871-81.
  26. Bonios MJ, Terrovitis JV, Drakos SG, Katsaros F, Pantsios C, Nanas SN, Kanakakis J, Alexopoulos G, Toumanidis S, Anastasiou-Nana M, Nanas JN (2011). Comparison of three different regimens of intermittent inotrope infusions for end stage heart failure. (Epub ahead of print) Int J Cardiol.
  27. Drakos SG, Terrovitis JV, Nanas JN, Charitos EI, Ntalianis AS, Malliaras KG, Diakos N, Koudoumas D, Theodoropoulos S, Yacoub MH, Anastasiou-Nana MI (2011). Reverse electrophysiologic remodeling after cardiac mechanical unloading for end-stage nonischemic cardiomyopathy. Ann Thorac Surg, 91(3), 764-9.
  28. Stavrakis S, Terrovitis J, Tsolakis E, Drakos S, Dalianis A, Bonios M, Koudoumas D, Malliaras K, Nanas J (2011). Relationship between retrograde coronary blood flow and the extent of no-reflow and infarct size in a porcine ischemia-reperfusion model. J Cardiovasc Transl Res, 4(1), 99-105.
  29. Verma DR, Drakos SG, Stehlik J, Horne BD, Kfoury AG (2010). Effect of preservation solution choice on antibody-mediated rejection after heart transplantation. J Heart Lung Transplant, 29(11), 1314-5.
  30. Singhal AK, Drakos SG, Kfoury AG, Horne BD, Verma DR, Stehlik J (2010). Prolonged allograft ischemic time is not associated with higher incidence of antibody-mediated rejection. J Heart Lung Transplant, 29(10), 1198-200.
  31. Tasoulis A, Papazachou O, Dimopoulos S, Gerovasili V, Karatzanos E, Kyprianou T, Drakos S, Anastasiou-Nana M, Roussos C, Nanas S (2010). Effects of interval exercise training on respiratory drive in patients with chronic heart failure. Respir Med, 104(10), 1557-65.
  32. Brush S, Budge D, Alharethi R, McCormick AJ, Macpherson JE, Reid BB, Ledford ID, Smith HK, Stoker S, Clayson SE, Doty JR, Caine WT, Drakos S, Kfoury AG (2010). End-of-life decision making and implementation in recipients of a destination left ventricular assist device. (Epub ahead of print) J Heart Lung Transplant.
  33. Kotter JR, Drakos SG, Horne BD, Hammond EH, Stehlik J, Bull DA, Reid BB, Gilbert EM, Everitt M, Alharethi R, Budge D, Verma DR, Li Y, Kfoury AG (2010). Effect of blood product transfusion-induced tolerance on incidence of cardiac allograft rejection. Transplant Proc, 42(7), 2687-92.
  34. Dimopoulos SK, Drakos SG, Terrovitis JV, Tzanis GS, Nanas SN (2010). Improvement in respiratory muscle dysfunction with continuous-flow left ventricular assist devices. J Heart Lung Transplant, 29(8), 906-8.
  35. Drakos SG, Kfoury AG, Hammond EH, Reid BB, Revelo MP, Rasmusson BY, Whitehead KJ, Salama ME, Selzman CH, Stehlik J, Clayson SE, Bristow MR, Renlund DG, Li DY (2010). Impact of mechanical unloading on microvasculature and associated central remodeling features of the failing human heart. J Am Coll Cardiol, 56(5), 382-91.
  36. Bull DA, Reid BB, Selzman CH, Mesley R, Drakos S, Clayson S, Stoddard G, Gilbert E, Stehlik J, Bader F, Kfoury A, Budge D, Eckels DD, Fuller A, Renlund D, Patel AN (2010). The impact of bridge-to-transplant ventricular assist device support on survival after cardiac transplantation. J Thorac Cardiovasc Surg, 140(1), 169-73.
  37. Drakos SG, Janicki L, Horne BD, Kfoury AG, Reid BB, Clayson S, Horton K, Haddad F, Li DY, Renlund DG, Fisher PW (2010). Risk factors predictive of right ventricular failure after left ventricular assist device implantation. Am J Cardiol, 105(7), 1030-5.
  38. Drakos SG, Athanasoulis T, Malliaras KG, Terrovitis JV, Diakos N, Koudoumas D, Ntalianis AS, Theodoropoulos SP, Yacoub MH, Nanas JN (2010). Myocardial sympathetic innervation and long-term left ventricular mechanical unloading. JACC Cardiovasc Imaging, 3(1), 64-70.
  39. Gerovasili V, Drakos S, Kravari M, Malliaras K, Karatzanos E, Dimopoulos S, Tasoulis A, Anastasiou-Nana M, Roussos C, Nanas S (2009). Physical exercise improves the peripheral microcirculation of patients with chronic heart failure. J Cardiopulm Rehabil Prev, 29(6), 385-91.
  40. Singhal AK, Sheng X, Drakos SG, Stehlik J (2009). Impact of donor cause of death on transplant outcomes: UNOS registry analysis. Transplant Proc, 41(9), 3539-44.
  41. Kfoury AG, Hammond ME, Snow GL, Drakos SG, Stehlik J, Fisher PW, Reid BB, Everitt MD, Bader FM, Renlund DG (2009). Cardiovascular mortality among heart transplant recipients with asymptomatic antibody-mediated or stable mixed cellular and antibody-mediated rejection. J Heart Lung Transplant, 28(8), 781-4.
  42. Drakos SG, Kfoury AG, Kotter JR, Reid BB, Clayson SE, Selzman CH, Stehlik J, Fisher PW, Merida M 3rd, Eckels DD, Brunisholz K, Horne BD, Stoker S, Li DY, Renlund DG (2009). Prior human leukocyte antigen-allosensitization and left ventricular assist device type affect degree of post-implantation human leukocyte antigen-allosensitization. J Heart Lung Transplant, 28(8), 838-42.
  43. Drakos SG, Bonios MJ, Anastasiou-Nana MI, Tsagalou EP, Terrovitis JV, Kaldara E, Maroulidis G, Nanas SN, Kanakakis J, Nanas JN (2009). Long-Term Survival and Outcomes After Hospitalization for Acute Myocardial Infarction Complicated by Cardiogenic Shock. Clin Cardiol, 32(8), E4-E8.
  44. Whitehead KJ, Chan AC, Navankasattusas S, Koh W, London NR, Ling J, Mayo AH, Drakos SG, Jones CA, Zhu W, Marchuk DA, Davis GE, Li DY (2009). The cerebral cavernous malformation signaling pathway promotes vascular integrity via Rho GTPases. Nat Med, 15(2), 177-84.
  45. Drakos SG, Kanakakis JV, Nanas S, Bonios M, Kaldara E, Katsaros F, Pantsios C, Nanas JN (2009). Intermittent inotropic infusions combined with prophylactic oral amiodarone for patients with decompensated end-stage heart failure. J Cardiovasc Pharmacol, 53(2), 157-61.
  46. Kanakakis J, Nanas JN, Tsagalou EP, Maroulidis GD, Drakos SG, Ntalianis AS, Tzoumele P, Skoumbourdis E, Charbis P, Rokas S, Anastasiou-Nana M (2009). Multicenter randomized trial of facilitated percutaneous coronary intervention with low-dose tenecteplase in patients with acute myocardial infarction: The Athens PCI trial. Catheter Cardiovasc Interv, 74(3), 398-405.
  47. Tsagalou EP, Kanakakis J, Anastasiou-Nana MI, Drakos SG, Ntalianis AS, Malliaras K, Lazaris N, Katsaros F, Nanas JN (2009). Hemodynamic effects of levosimendan in acute myocardial infarction complicated by cardiogenic shock and high systemic vascular resistance. Acute Card Care, 11(2), 99-106.
  48. Drakos SG, Anastasiou-Nana MI, Terrovitis JV, Tsagalou EP, Kanakakis J, Ntalianis A, Lazaris N, Maroulidis G, Venetsanakos J, Bonios M, Nanas JN (2008). Intra-aortic balloon counterpulsation and delayed revascularization for myocardial infarction and shock in the absence of primary angioplasty: a treatment strategy with or without thrombolysis? Coron Artery Dis, 19(7), 521-6.
  49. Ntalianis AS, Drakos SG, Charitos C, Dolou P, Pierrakos CN, Terrovitis JV, Papaioannou T, Charitos E, Nanas JN (2008). Effects of intra-aortic balloon pump versus centrifugal pump on myocardial energetics and systemic circulation in a porcine model of rapidly worsening acute heart failure. ASAIO J, 54(6), 600-5.
  50. Tsagalou EP, Anastasiou-Nana M, Agapitos E, Gika A, Drakos SG, Terrovitis JV, Ntalianis A, Nanas JN (2008). Depressed coronary flow reserve is associated with decreased myocardial capillary density in patients with heart failure due to idiopathic dilated cardiomyopathy. J Am Coll Cardiol, 52(17), 1391-8.
  51. Bonios MJ, Pierrakos CN, Argiriou M, Dalianis A, Terrovitis JV, Dolou P, Drakos SG, Koudoumas D, Charitos CE, Anastasiou-Nana MI (2008). Increase in coronary blood flow by intra-aortic balloon counterpulsation in a porcine model of myocardial reperfusion. (Epub ahead of print) Int J Cardiol.
  52. Struber M, Sander K, Lahpor J, Ahn H, Litzler PY, Drakos SG, Musumeci F, Schlensak C, Friedrich I, Gustafsson R, Oertel F, Leprince P (2008). HeartMate II left ventricular assist device; early European experience. Eur J Cardiothorac Surg, 34(2), 289-94.
  53. Kravari M, Vasileiadis I, Gerovasili V, Karatzanos E, Tasoulis A, Kalligras K, Drakos SG, Dimopoulos S, Anastasiou-Nana M, Nanas S (2008). Effects of a 3-month rehabilitation program on muscle oxygenation in congestive heart failure patients as assessed by NIRS. Int J Ind Ergon.
  54. Drakos SG, Kfoury AG, Long JW, Stringham JC, Gilbert EM, Horne BD, Hagan MB, Nelson K, Renlund DG (2007). Similar transplantation outcomes in patients bridged with cardiac assist devices for acute cardiogenic shock versus chronic heart failure. Eur J Heart Fail, 9(8), 845-9.
  55. Drakos SG, Stringham JC, Long JW, Gilbert EM, Fuller TC, Campbell BK, Horne BD, Hagan ME, Nelson KE, Lindblom JM, Meldrum PA, Carlson JF, Moore SA, Kfoury AG, Renlund DG (2007). Prevalence and risks of allosensitization in HeartMate left ventricular assist device recipients: the impact of leukofiltered cellular blood product transfusions. J Thorac Cardiovasc Surg, 133(6), 1612-9.
  56. Papazachou O, Anastasiou-Nana M, Sakellariou D, Tassiou A, Dimopoulos S, Venetsanakos J, Maroulidis G, Drakos S, Roussos C, Nanas S (2007). Pulmonary function at peak exercise in patients with chronic heart failure. Int J Cardiol, 118(1), 28-35.
  57. Drakos SG, Kfoury AG, Gilbert EM, Horne BD, Long JW, Stringham JC, Campbell BA, Renlund DG (2007). Effect of reversible pulmonary hypertension on outcomes after heart transplantation. J Heart Lung Transplant, 26(4), 319-23.
  58. Drakos SG, Kfoury AG, Gilbert EM, Long JW, Stringham JC, Hammond EH, Jones KW, Bull DA, Hagan ME, Folsom JW, Horne BD, Renlund DG (2007). Multivariate predictors of heart transplantation outcomes in the era of chronic mechanical circulatory support. Ann Thorac Surg, 83(1), 62-7.
  59. Nanas JN, Matsouka C, Karageorgopoulos D, Leonti A, Tsolakis E, Drakos SG, Tsagalou EP, Maroulidis GD, Alexopoulos GP, Kanakakis JE, Anastasiou-Nana MI (2006). Etiology of anemia in patients with advanced heart failure. J Am Coll Cardiol, 48(12), 2485-9.
  60. Drakos SG, Kfoury AG, Long JW, Stringham JC, Fuller TC, Nelson KE, Campbell BK, Gilbert EM, Renlund DG (2006). Low-dose prophylactic intravenous immunoglobulin does not prevent HLA sensitization in left ventricular assist device recipients. Ann Thorac Surg, 82(3), 889-93.
  61. Nanas SN, Nanas JN, Sakellariou DCh, Dimopoulos SK, Drakos SG, Kapsimalakou SG, Mpatziou CA, Papazachou OG, Dalianis AS, Anastasiou-Nana MI, Roussos C (2006). VE/VCO2 slope is associated with abnormal resting haemodynamics and is a predictor of long-term survival in chronic heart failure. Eur J Heart Fail, 8(4), 420-7.
  62. Terrovitis JV, Anastasiou-Nana MI, Alexopoulos GP, Tsolakis EJ, Margari ZJ, Drakos SG, Tsagalou EP, Papazoglou P, Efentakis S, Nanas JN (2006). Prevalence and prognostic significance of anemia in patients with congestive heart failure treated with standard vs high doses of enalapril. J Heart Lung Transplant, 25(3), 333-8.
  63. Drakos SG, Kfoury AG, Long JW, Stringham JC, Gilbert EM, Moore SA, Campbell BK, Nelson KE, Horne BD, Renlund DG (2006). Effect of mechanical circulatory support on outcomes after heart transplantation. J Heart Lung Transplant, 25(1), 22-8.
  64. Dimopoulos S, Anastasiou-Nana M, Sakellariou D, Drakos SG, Kapsimalakou S, Maroulidis G, Roditis P, Roussos C, Nanas S (2006). Effects of exercise rehabilitation program on heart rate recovery in patients with chronic heart failure. Eur J Cardiovasc Prev Rehabil, 13(1), 67-73.
  65. Anastasiou-Nana MI, Tsagalou EP, Mavrikakis EM, Siafakas KX, Tsolakis EJ, Drakos SG, Dalianis A, Karelas J, Terrovitis JV, Nanas JN (2005). Myocardial ischaemic preconditioning in the pig has no effect on the ventricular fibrillation and defibrillation thresholds. Resuscitation, 64(3), 373-6.
  66. Anastasiou-Nana MI, Tsagalou EP, Charitos C, Siafakas KX, Drakos S, Terrovitis JV, Ntalianis A, Doufas A, Mavrikakis J, Nanas JN (2005). Effects of transient myocardial ischemia on the ventricular defibrillation threshold. Pacing Clin Electrophysiol, 28(2), 97-101.
  67. Drakos SG, Charitos CE, Ntalianis A, Terrovitis JV, Siafakas KX, Dolou P, Pierrakos C, Charitos E, Karelas J, Nanas JN (2005). Comparison of pulsatile with nonpulsatile mechanical support in a porcine model of profound cardiogenic shock. ASAIO J, 51(1), 26-9.
  68. Nanas JN, Tsolakis E, Terrovitis JV, Eleftheriou A, Drakos SG, Dalianis A, Charitos CE (2004). Moderate systemic hypotension during reperfusion reduces the coronary blood flow and increases the size of myocardial infarction in pigs. Chest, 125(4), 1492-9.
  69. Tsagalou EP, Anastasiou-Nana MI, Charitos CE, Siafakas CX, Drakos SG, Ntalianis A, Terrovitis JV, Mavrikakis EM, Doufas A, Nanas JN (2004). Time course of fibrillation and defibrillation thresholds after an intravenous bolus of amiodarone--an experimental study. Resuscitation, 61(1), 83-9.
  70. Drakos SG, Papamichael CM, Alexopoulos GP, Anastasiou-Nana MI, Stathopoulos JV, Nanas JN (2003). Effects of high doses versus standard doses of enalapril on endothelial cell function in patients with chronic congestive heart failure secondary to idiopathic dilated or ischemic cardiomyopathy. Am J Cardiol, 91(7), 885-8.
  71. Nanas S, Nanas J, Kassiotis C, Nikolaou C, Tsagalou E, Sakellariou D, Terovitis I, Papazachou O, Drakos S, Papamichalopoulos A, Roussos C (2001). Early recovery of oxygen kinetics after submaximal exercise test predicts functional capacity in patients with chronic heart failure. Eur J Heart Fail, 3(6), 685-92.
  72. Drakos SG, AnastasiouNana M, Nanas J (2001). Exacerbation of variant angina by metoprolol resulting in syncope due to transient atrioventricular block. Int J Cardiol, 82, 83-85.
  73. Ziras N, Rozakou A, Skoura S, Drakos S, Venetsanou V, Tsiggalakis D, Fragaki 924, Giannakakis T, Athanassiou A (2001). Soluble transferrin receptor: An early predicting index of response to epoetin alfa treatment for the prophylaxis of chemotherapy-induced anemia in patients with solid tumors. J BUON, 6, 67-73.

Review

  1. Wever-Pinzon O, Stehlik J, Kfoury AG, Terrovitis JV, Diakos NA, Charitos C, Li DY, Drakos SG (2012). Ventricular assist devices: pharmacological aspects of a mechanical therapy. [Review]. Pharmacology & Therapeutics, 134(2), 189-99.
  2. Drakos SG, Kfoury AG, Selzman CH, Verma DR, Nanas JN, Li DY, Stehlik J (2011). Left ventricular assist device unloading effects on myocardial structure and function: current status of the field and call for action. [Review]. Curr Opin Cardiol, 26(3), 245-55.
  3. Drakos SG, Anastasiou-Nana MI, Malliaras KG, Nanas JN (2009). Anemia in chronic heart failure. [Review]. Congestive Heart Failure, 15(2), 87-92.
  4. Malliaras KG, Terrovitis JV, Drakos SG, Nanas JN (2009). Reverse cardiac remodeling enabled by mechanical unloading of the left ventricle. [Review]. Journal of Cardiovascular Translational Research, 2(1), 114-25.
  5. Terrovitis JV, Anastasiou-Nana M, Kaldara E, Drakos SG, Nanas SN, Nanas JN (2009). Anemia in heart failure: pathophysiologic insights and treatment options. [Review]. Future Cardiology, 5(1), 71-81.
  6. Drakos SG, Terrovitis JV, Anastasiou-Nana MI, Nanas JN (2007). Reverse remodeling during long-term mechanical unloading of the left ventricle. [Review]. J Mol Cell Cardiol, 43(3), 231-42.
  7. Drakos SG, Charitos EI, Nanas SN, Nanas JN (2007). Ventricular-assist devices for the treatment of chronic heart failure. [Review]. Expert Rev Cardiovasc Ther, 5(3), 571-84.

Book Chapter

  1. Diakos NA, Wever-Pinzon O, Zannas AS, Drakos SG (2013). Mechanical unloading and heart remodeling features. In Edmo Gabriel, Sthefano Gabriel (Eds.), Inflammatory response in cardiovascular surgery, New York, NY: Springer.
  2. Terrovitis JV, Tseliou E, Drakos SG, Nanas JN (2011). Evaluation of Cardiac Function after VAD Implantation, New Aspects of Ventricular Assist Devices, Guillermo Reyes (Ed.), ISBN: 978-953-307-676-8, InTech, Available from : http://www.intechopen.com/books.
  3. Tsagalou EP, Drakos SG, Tsolakis E, Nanas J (2008). Intra-aortic balloon pump in the management of acute heart failure syndromes. In Alexandre Mebazaa, Mihai Gheorghiade, Faiez Zannad, Joseph Parrillo (Eds.), Acute Heart Failure (pp. 671-684). New York, NY: Springer.
  4. Drakos SG, Alexopoulos G, Nanas JN (2005). Organizing a heart failure program. In Filippatos G, Adamopoulos S, Parissis J, Anthopoulos L, Kremastinos D (Eds.), Heart Failure: from diagnosis to treatment (pp. 453-464). Athens, Greece: Paschalides Editions.

Conference Proceedings

  1. Drakos SG, Bonios M, Terrovitis JV, Panagiotopoulos G, Pozios I, Diakos N, Tseliou E, Malliaras K, Kanakakis J, Anastasiou-Nana MI (2009). Commonly used risk factors failed to accurately predict survival in patients with advanced heart failure. (Indexed in Current Contents of ISI, Philadelphia, USA). Proceedings of the 14th World Congress on Heart Disease, 251.
  2. Bonios M, Drakos SG, Anastasiou-Nana M, Tsagalou E, Ntalianis A, Maroulidis G, Venetsanakos J, Lazaris N, Kanakakis J, Nanas J (2007). Prognosis of Post-Myocardial Infarction Cardiogenic Shock Patients that Require Mechanical Ventilation. (indexed in Current Contents of ISI, Philadelphia, USA). Proceedings of the 13th World Congress on Heart Dis, XV, 383-7.

Clinical Trials

Video & News

News

Video